With these key players in the Trump administration putting their support behind cannabis reform measures, we could be closer to legalization – and massive profits – than anyone imagined.

The United States will legalize cannabis.

With all the competing legalization efforts out there, I want to make sure you understand that clearly. One way or another, marijuana will become legal.

Knowing how and when is the ultimate goal. The ability to position yourself ahead of a catalyst like the federal legalization of marijuana could open the door to a retirement fortune unlike anything we’ve ever seen before.

We’ve talked about a few different ways legalization could happen, from various bills all the way through an executive order.

And now another effort has been thrown into the mix.

Just last week, Senator Cory Booker (D-NJ) introduced his Marijuana Justice Act, which would both end federal prohibition and repair the damage that prohibition’s harsh sentencing guidelines caused.

While the bill would undoubtedly accomplish a lot of good, it has yet to garner any Republican support.

Meanwhile, the STATES Act and the SAFE Banking Act are continuing to gain bipartisan steam.

And the support of two high-ranking Trump administration officials could be the straw to break the camel’s back…

When a “Significant Issue” Meets an “Untenable System”

Last week, while testifying before the House Committee on Financial Services, Treasury Secretary Steven Mnuchin pledged to thoroughly review and consider the Secure and Fair Enforcement (SAFE) Banking Act.

This bill, the first piece of federal cannabis reform legislation ever to reach the House floor, would open the doors of banks to cannabis businesses. Most banks currently won’t deal with these businesses, fearing that by taking money from a federally illegal business, they will be accused of money laundering.

Mnuchin called this a “significant issue,” and when asked to review and consider endorsing the SAFE Banking Act within two weeks, he said he’d be “happy to review it and my staff will follow up.”

This industry has turned average folks into millionaires before… and with one move, you can be next. But your window to act is shrinking with every passing day. To get in before it vanishes altogether, go here.

Floor action is expected within the next few weeks, and the bill looks increasingly likely to move on to the Senate.

Even as the Treasury considers that historic piece of legislation, the Justice Department is already looking into the Strengthening the Tenth Amendment Through Entrusting States (STATES) Act.

Attorney General William Barr believes the current system, in which cannabis is legal in many states despite federal prohibition, is akin to a “backdoor nullification of federal law.”

Barr, who even admits his preference for blanket prohibition, says “the current situation is untenable,” and that he would “much rather… the approach taken by the STATES Act than where we currently are.”

Going All In

When will cannabis be legalized in the U.S.? No one can say for sure.

But things are moving fast. Politicians from both sides of the aisle – from former House Speaker John Boehner to former Vermont Governor Howard Dean – have reversed their anti-cannabis leanings and are “going all in.”

And as these two bills continue to gain momentum and hurdle through the legislative process, I want to make sure you have all the tools necessary to position yourself for the biggest gains when U.S. legalization becomes a reality.

Don’t get left behind.

Before I Go…

The cannabis market has been under pressure for a couple of weeks, and it took a beating yesterday. The catalyst this time at least seems to have something to do with cannabis, unlike the decline in November and December of last year.

Specifically, some of the large Canadian producers are announcing lackluster results. The latest was Aphria (NYSE: APHA), which had disappointing cannabis revenues during its quarter ended February 28, 2019. Aphria attributed the company’s shortfall to supply shortages and packaging and distribution difficulties.

The market is right to be concerned about Aphria’s results – cannabis revenue should not be falling in Canada, despite the difficulties that country has had with adult-use cannabis since it became legal in October of last year.

But the longer-term picture is still bright for Aphria. It’s even brighter for other Canadian suppliers, and it’s amazing for American producers, which are not at all affected by the troubles facing the larger Canadian suppliers.

And that means that this decline is a good entry point for those of you who have not yet purchased cannabis stocks or who have been waiting to increase your positions in these stocks. I always prefer buying in down markets to buying when everyone else is rushing to get in.

In particular, the American stocks in the Cannabis Investor’s Report model portfolio are outstanding values right now, and we were even able to complete a position at a “discount” yesterday thanks to the recent volatility.

Over the next few weeks, we’re going to continue sharing the best tips and strategies for not only navigating these downturns, but using them to our greatest advantage to make a handsome profit.

Greg Miller
Executive Director, National Institute for Cannabis Investors

P.S. Right now, you can find hundreds of pot stocks trading for pennies on the dollar. But when it comes to picking out who will lead the pack in this quickly maturing group… that’s a different story. Most investors have seriously overlooked the enormous potential of penny pot stocks. But believe me when I say that this $2 pot stock could be the key to the kind of millionaire-making gains we’ve witnessed in the past. We’ve assembled a team to do all the legwork for you… and we’ve poured over nearly every cannabis stock on the market to find our top three recommendations. As we speak, these could be gearing up for a MASSIVE upward surge. And if you make your move before the rest of the world catches up, you can ride America’s green wave all the way to the bank. There’s no doubt that the cannabis market is set to multiply another 5, 10, even 20 times over in the coming years. And from what we’ve seen in the past, this action could mint a brand-new class of marijuana millionaires. To see how to stake your claim in America’s fastest-growing industry, go here now.


4 responses to “High-Ranking Trump Officials Show Cannabis Support”

  1. Agreed, and the US cannabis companies will soar once Wall Street stops treating the sector as one, and stops factoring in US companies with disappointing earnings and other issues associated with the Canadian LP”S. There will be separation with stud horse companies amongst the best in the coming months and years and the disapointing Canadian LP’s will be IRRELEVANT in the US. We are being told that the sector being treated as one by Wall Street is coming to an end. In other words, the best companies will magnify and multiply with growth and institutional money and the inferior companies will get what they have coming to them as well.

  2. Hi Greg,
    As a 8o+ Gentleman of Beautiful State of Montana–When will this Stock (Emerald Health Pharmaceuticals) OTC, Will be available for us Lifetime Investors….If you know…
    Appreciate any information on this when it goes OTC….
    Thanks for all your updates
    Dennis Wilson

    we areLifetime cannabis Investors..

  3. The longer legalization of cannabis is delayed, is only giving foreign competition the edge.

Leave a Reply

Your email address will not be published. Required fields are marked *